Quinacrine dihydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Quinacrine dihydrochloride, covering 2016-10-31 to 2016-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer [Phase 1]